•  
  •  
 

Lynchburg Journal of Medical Science

Lynchburg Journal of Medical Science

Specialty

Autoinflammatory and Autoimmune Disease

Advisor

Professor Thomas Colletti, DHSc, MPAS, PA-C

Abstract

ABSTRACT

The purpose of this article is to review the potential impact of anti-drug antibody (ADA) development on the safety and efficacy of biotherapeutics when treating autoinflammatory and autoimmune diseases. Awareness of ADAs can assist providers in making treatment decisions in their autoimmune and autoinflammatory patients, such as biotherapeutic drug or class switch.

Restricted

Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.

Off-campus users can also use 'Off-campus Download' button above for access.

Share

COinS